PRIME Cohort Studies

The cohort studies are treatment cohorts which assessed the clinical, social and economic outcomes of patients who have<br>received a diagnosis of depression, alcohol use disorder (AUD), psychosis or epilepsy. In some countries a control group<br>(patients who screen positive for a disorder but were undiagnosed by a clinician) were also followed up. Key research<br>themes included social, health and economic outcomes, equity of access, and stigma, discrimination, adherence and<br>retention in care. After the baseline data collection, patients were followed-up after 3 or 6 months (midline visit), and<br>again 12 months after the baseline (endline visit). A detailed description of the cohort methods has been published in<br>BMC Psychiatry (https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1642-x). Below is a brief<br>overview of the design, recruitment and data collection methods.<br>If you wish to access the cohort dataset, please complete an expression of interest form at<br>https://docs.google.com/forms/d/e/1FAIpQLSfp9sVy_OKV18AWJfUlBGVnC_QuLyCalR4xVJR4tAMRR5g1wg/viewform.